XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 154 filers reported holding XENON PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,754,423 | +284.0% | 80,633 | +332.7% | 0.01% | +250.0% |
| Q2 2023 | $717,371 | +75.0% | 18,633 | +62.7% | 0.00% | +100.0% |
| Q1 2023 | $409,939 | -79.7% | 11,454 | -79.5% | 0.00% | -85.7% |
| Q3 2022 | $2,021,000 | -71.6% | 55,974 | -75.9% | 0.01% | -66.7% |
| Q1 2022 | $7,112,000 | -18.2% | 232,650 | -16.4% | 0.02% | +10.5% |
| Q4 2021 | $8,695,000 | +235.3% | 278,343 | +64.0% | 0.02% | +216.7% |
| Q3 2021 | $2,593,000 | +63.4% | 169,676 | +99.1% | 0.01% | +50.0% |
| Q2 2021 | $1,587,000 | +15.6% | 85,218 | +11.1% | 0.00% | 0.0% |
| Q1 2021 | $1,373,000 | +76.5% | 76,706 | +51.7% | 0.00% | +100.0% |
| Q4 2020 | $778,000 | +40.7% | 50,561 | +1.2% | 0.00% | 0.0% |
| Q3 2020 | $553,000 | -63.3% | 49,985 | -58.4% | 0.00% | -71.4% |
| Q2 2020 | $1,506,000 | +49.9% | 120,115 | +35.6% | 0.01% | -12.5% |
| Q1 2020 | $1,005,000 | -0.2% | 88,605 | +15.3% | 0.01% | +166.7% |
| Q4 2019 | $1,007,000 | +70.4% | 76,817 | +32.1% | 0.00% | +50.0% |
| Q1 2019 | $591,000 | -53.2% | 58,149 | -71.0% | 0.00% | -60.0% |
| Q4 2018 | $1,264,000 | +25.0% | 200,261 | +161.5% | 0.01% | +66.7% |
| Q3 2018 | $1,011,000 | – | 76,585 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 266,961 | $9,119,388 | 10.70% |
| COMMODORE CAPITAL LP | 1,845,000 | $63,025,200 | 7.37% |
| TLS Advisors LLC | 32,956 | $1,126 | 4.56% |
| Altium Capital Management LP | 228,000 | $7,788,480 | 4.06% |
| Paradigm Biocapital Advisors LP | 1,491,835 | $50,961,084 | 3.46% |
| GREAT POINT PARTNERS LLC | 500,001 | $17,080,034 | 3.11% |
| DAFNA Capital Management LLC | 280,538 | $9,583,178 | 2.98% |
| Nan Fung Group Holdings Ltd | 106,680 | $3,644,189 | 2.95% |
| Affinity Asset Advisors, LLC | 300,438 | $10,262,962 | 2.89% |
| Avoro Capital Advisors LLC | 4,900,000 | $167,384,000 | 2.61% |